Summary: The DNAJ-PKAc fusion kinase is a defining feature of fibrolamellar carcinoma (FLC). FLC tumors are notoriously resistant to standard chemotherapies. with aberrant kinase activity assumed to be a contributing factor. By combining proximity proteomics. https://www.bekindtopets.com/quick-grab-Canine-Spectra-KC-3-Single-Dose-great-price/